"Save Antibiotics, Save lives": an Indian success story of infection control through persuasive diplomacy
- PMID: 22958711
- PMCID: PMC3508860
- DOI: 10.1186/2047-2994-1-29
"Save Antibiotics, Save lives": an Indian success story of infection control through persuasive diplomacy
Abstract
Background: Carbapenem resistant Enterobacteriaceae is a worldwide threat, with increasing prevalence in many countries. Restricted usage of higher end antibiotics, especially carbapenem is of great importance in tackling these super bugs. Purpose of this retrospective study was to analyse the impact of antibiotic stewardship activities on the prevalence of carbapenem resistant Enterobacteriaceae in our hospital.
Findings: In the first Quarter of 2009, average usage of carbapenem group of antibiotics was 955 vials a month while in 2010, the usage dropped to 745 vials per month. Carbapenem resistant E.coli rate dropped from 3.7% in 2009 to 1.6% in 2010 and Klebsiella rate reduced from 6% in 2009 to 3.6% in 2010.
Conclusions: Strict antibiotic stewardship strategies in conjunction with good infection control practices are useful in restricting higher end antibiotic usage and reducing the prevalence of carbapenem resistant Enterobacteriaceae.
Figures
Similar articles
-
Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.J Infect Public Health. 2019 Mar-Apr;12(2):195-199. doi: 10.1016/j.jiph.2018.10.003. Epub 2018 Oct 29. J Infect Public Health. 2019. PMID: 30385238
-
[Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].Zhonghua Er Ke Za Zhi. 2019 Jul 2;57(7):553-558. doi: 10.3760/cma.j.issn.0578-1310.2019.07.012. Zhonghua Er Ke Za Zhi. 2019. PMID: 31269557 Chinese.
-
Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand.J Clin Pharm Ther. 2019 Apr;44(2):292-299. doi: 10.1111/jcpt.12791. Epub 2018 Dec 21. J Clin Pharm Ther. 2019. PMID: 30578578
-
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam.Infect Dis Ther. 2020 Dec;9(4):769-784. doi: 10.1007/s40121-020-00344-z. Epub 2020 Oct 6. Infect Dis Ther. 2020. PMID: 33025557 Free PMC article. Review.
-
Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.Infez Med. 2019 Dec 1;27(4):357-364. Infez Med. 2019. PMID: 31846984 Review.
Cited by
-
Risk Factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection: A Five-Year Retrospective Study.Infect Drug Resist. 2022 Feb 25;15:641-654. doi: 10.2147/IDR.S342103. eCollection 2022. Infect Drug Resist. 2022. PMID: 35241916 Free PMC article.
-
Antibiotic stewardship initiative in a Medicine unit of a tertiary care teaching hospital in India: A pilot study.Indian J Med Res. 2019 Aug;150(2):175-185. doi: 10.4103/ijmr.IJMR_951_17. Indian J Med Res. 2019. PMID: 31670273 Free PMC article.
-
Implementation of an antimicrobial stewardship programme and reduction in carbapenemase-producing Enterobacterales in an Australian local health district.JAC Antimicrob Resist. 2020 Jul 13;2(3):dlaa041. doi: 10.1093/jacamr/dlaa041. eCollection 2020 Sep. JAC Antimicrob Resist. 2020. PMID: 34223004 Free PMC article.
-
Reversing the Trend of Antimicrobial Resistance in ICU: Role of Antimicrobial and Diagnostic Stewardship.Indian J Crit Care Med. 2021 Jun;25(6):635-641. doi: 10.5005/jp-journals-10071-23861. Indian J Crit Care Med. 2021. PMID: 34316142 Free PMC article.
-
Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.Expert Rev Anti Infect Ther. 2014 May;12(5):565-80. doi: 10.1586/14787210.2014.902306. Epub 2014 Mar 25. Expert Rev Anti Infect Ther. 2014. PMID: 24666262 Free PMC article. Review.
References
-
- Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hegde A, Soman R. New Delhi Metallo-b lactamase (NDM-1) in Enterobacteriaceae: Treatment options with Carbapenems Compromised. JAPI. 2010;58:146–148. - PubMed
LinkOut - more resources
Full Text Sources